SIBTECH, INC.
Medtech · Defunct
18F PET tracer for VEGFR molecular imaging in oncology
- Grants
- $1.7M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $2.8M
- 4 awards · Defense, Health and Human S
- #181 of 4531 in medtech
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf To Target Specific Molecular Imaging Agents In Combination With Existing Imaging Modalities To Detect High Risk Atherosclerotic Plaque | $224,944 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted drug delivery to tumor microenvironment | $224,833 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical development of 18F PET tracer for imaging VEGF receptors | $1,016,118 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Systemic Radionuclide Therapy Targeted To Vegf Receptors In Tumor Vasculature | $2,256,052 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical development of 18F PET tracer for imaging VEGF receptors | $456,892 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Topic 375: 18F Pet Tracer For Imaging PD-L1 (moonshot) | $299,735 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 178 | COLUMBUS NANOWORKS, INC. | $2.8M | — |
| 179 | CELLSIGHT TECHNOLOGIES, INC. | $2.8M | — |
| 180 | MAXQ RESEARCH LLC | $2.8M | — |
| 181 | SIBTECH, INC. | $2.8M | — |
| 182 | NVIGEN | $2.7M | $1.1M |
| 183 | LUMOSTECH, INC. | $2.7M | — |
| 184 | Sword Health | $2.6M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- A Cysteine-containing Peptide Tag For Site-specific Conjugation Of Proteinsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.